Fed Cut Hopes, Hollywood Bidding War, CVS Steps Up

Good Morning Investors!!! Markets are walking into a packed day. The Federal Reserve starts its final meeting of 2025 with stocks on edge and rate cut hopes in the air. Hollywood is running its own drama as Paramount tries to outbid Netflix for Warner Bros Discovery in a huge media deal. On the more defensive side, utilities have cooled after a strong run, while CVS used its Investor Day to lift its profit goals and pitch a tighter, tech heavy health care plan.

Happenings in the Markets

Thoughts from InvestorsGrow:

Today is a big day for the job market story, even if you never look at a single spreadsheet. The NFIB index tells us how small business owners on Main Street feel about sales, hiring, and costs. When that index sits near or above its long run average, it suggests owners are cautious but still willing to invest and hire. A drop would hint that they are pulling in their horns and could cool job growth. A stronger reading would say the small business engine is still humming, even if it is not at full roar.

The JOLTS report is like a dating app for jobs. It shows how many roles are open and how many people are quitting on purpose. Economists look for job openings to ease a bit from earlier in the year rather than fall off a cliff. A sharp drop would back the idea that the labor market is cooling and could give the Fed more comfort to cut rates. A surprise jump in openings would point to a still tight job market and might make some Fed officials worry that wage growth will stay too hot for their liking.

Tomorrow is the main event. The Employment Cost Index tracks how fast pay and benefits are rising across the economy and lands just hours before the Fed announces its final rate move of 2025. If compensation is still growing near recent peaks, the committee may lean toward a cautious message even if it trims rates. A softer wage number would let them argue that inflation pressures are easing and that cuts are less risky. In short, wages plus JOLTS are the clue book the Fed will read before it decides how much help to give borrowers next year.

Earnings today add a fun little side quest. AutoZone and Casey’s tell us how drivers are coping with car repairs and road trip costs. Campbell Soup gives a peek into pantry and comfort food budgets as the weather turns cold. After the close, GameStop and Dave & Buster’s show whether gamers and date nights are still spending or staying home. Think of this cluster of reports as a report card on everyday life in strip malls and truck stops across America. As always, this is for education only and not a nudge to buy or sell any stock.

Industry Spotlight

Utilities

Utilities are the firms that keep the lights on, heat flowing, and water running. They sell power and water, often in regulated markets, and are known for slow, steady dividends. Now they have a new twist as artificial intelligence (AI) data centers and cloud computing demand more electricity, so power demand forecasts are climbing. The Utilities Select Sector SPDR Fund (XLU) (exchange traded fund (ETF) for big U.S. utilities) is still higher than a year ago.

Over the past week though, XLU has slipped roughly 4%, which makes utilities one of the weaker sectors. Bond yields still offer stiff competition to utility dividend yields, so some investors have taken profits and moved cash into Treasuries and money funds. Options trading in several utility stocks has also picked up, with a jump in implied volatility at a major U.S. water utility ahead of possible rate or regulatory news.

Utilities Select Sector SPDR Fund (XLU) - 1 Year

NextEra Energy (NEE):

One of the largest U.S. power companies, with clean and gas plants. It just raised its profit outlook after AI data center power deals, though those projects also mean heavy spending and execution risk.

American Water Works (AWK):

The biggest publicly traded U.S. water and wastewater utility. Its options recently showed a jump in implied volatility, hinting that traders expect a larger price move around upcoming rate or regulatory news.

RWE (RWEGY):

A German based utility with large wind and solar assets in Europe and the U.S. It offers a global angle on the same AI driven power demand theme, but adds currency swings and European policy risk.

InvestorsGrow Takeaway:

Utilities may look dull, yet they sit at the crossroads of interest rates and the AI boom. In the short term, sector ETFs such as XLU can swing when yields move or headlines hit. Over the long run, rising electricity use could help some utilities grow faster than their sleepy image suggests. Think of them as part bond, part tech sidekick, and treat options spikes as a signal to research, not a to do list. This is education only, not investment advice.

Company Spotlight

CVS Health (CVS)

CVS Health (CVS) runs a large chain of drugstores and also sells health insurance. It fills prescriptions, runs clinics, and manages health plans. Through Aetna and CVS Caremark, it acts as a pharmacy benefit manager (PBM) that helps plans design drug coverage and try to control costs.

Today the company is hosting an Investor Day and rolling out a new plan. It raised its 2025 forecast for adjusted earnings per share (EPS) (profit for each share) to a range of 6.60 to 6.70 dollars. Plain-English data point: management now thinks each share will earn a bit more than before. CVS also guided to more profit growth in 2026 and beyond. The stock was up around 1 percent in early trading as of about 7:30 AM ET.

CVS Health (CVS) DCF Fair Value

This update matters because CVS sits between you and the health care system. If it can grow profit while keeping medical costs under control, that can support its stock and other managed care names. The plan leans on cost cuts, better results at Aetna, and new digital tools, including an Engagement as a Service platform that nudges people to refill meds, book visits, and avoid pricey hospital stays.

InvestorsGrow Takeaway:

Picture CVS as a mash up of your corner drugstore and a health data control room. The higher profit targets suggest the turnaround is gaining traction, but rising medical claims, pressure from regulators, and heavy tech spending could still trip it up. If you follow the stock, watch Aetna margins, cash flow, and early proof that the new tech tools save money. This is for learning, not a buy or sell call.

Related Posts

Related Articles

Sign Up for Free Investing Insights!

We don’t spam! Read our privacy policy for more info.